Network
Network
The EMIG Network includes approximately 1,500 individuals from Member companies and organisations, ranging from pharma companies to Associate Members offering vital services. Our membership also extends to patient charities, research organisations, and universities, all of which benefit from free membership.
Members can access collective expertise through our 'Network Questions' service. This allows any member to anonymously submit a question or request assistance via our web portal, with responses made freely available in the members' area.
Can anyone advise if a parallel import company can use a brand name of a product to gain a parallel import licence even when the product has been debranded for over 2 years ?
Distribution Partner
We are searching for a small devices company who can support with the logistics of shipping devices
The Accessus Group has just released “Vital Signs: Decoding UK Payers,” a report exploring the payer perspective to inform smarter NHS engagement strategies.
An EMIG member company is looking to train an in-house RP to become a QP over the next 12-18 months as part of their development.
Can anyone advise if the EU competent authorities accept UK GMP inpection outcomes.
Contracting Requirements for Third Party Rare Disease Screening Services
Does anyone have experience of an EU MS Reference Regulator prohibiting the sharing of assessment reports with the MHRA?
The son of an EMIG pharma company Member is seeking an internship for this summer.
We are looking for a simple eCTD system without a document repository and document management database.
I am seeking to understand if there are any companies that have recently debranded a product in response to VPAG?
We need a Medical Director on contract at short notice due to an unexpected situation.
We have been approached by a start-up spin-out pharmaceutical company seeking a suitable buyer for their asset, a Non Opioid Pain / Osteoarthritis pre-clinical API.
How are companies reporting TOV Homecare arrangements in line with PMCPA package deal guidance
Please can anyone advise of the Global Marketing Authorisation ( GMA )
Where a patent protected medicine is currently supplied under a NICE-approved PAS
What are the hourly rates for HCPs you may use for consultancy services in relation to educational projects?
I have been contacted by a pharmacist who is looking to transition to a new role in medical affairs in industry.
An EMIG member company is looking for recommendations regarding a UK site for QP testing and release of a biologic product for the UK market.
Has anyone successfully secured a positive NICE recommendation for a digital therapeutic using a real-world evidence (RWE) study design?
Please can anyone advise if a new MAA is submitted in prior to Jan 2025 via a DCP, with Northern Ireland as a CMS
NHS Formulary Application Pack Development Support
Looking for a vendor with experience producing a Carbon Reduction Plan.
Can you help with a TOPRA MSc thesis?
Can anyone advise if the MHRA will accept a generic national MAA if the reference medicinal product is discontinued?